Literature DB >> 8376516

Determination of cyclophosphamide in urine by gas chromatography-mass spectrometry.

P J Sessink1, M M Scholtes, R B Anzion, R P Bos.   

Abstract

A sensitive gas chromatographic method for the determination of cyclophosphamide in urine is presented. After liquid-liquid extraction with diethyl ether and derivatization with trifluoroacetic anhydride, cyclophosphamide was identified and quantified with mass spectrometry. The method is suitable for the determination of cyclophosphamide at concentrations of more than 0.25 ng/ml, which enables the uptake of cyclophosphamide during occupational activities, such as the preparation and administration of antineoplastic agents in hospitals, to be measured. Simple preparation makes the method appropriate for routine analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376516     DOI: 10.1016/0378-4347(93)80404-r

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

2.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

3.  Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.

Authors:  Wouter Fransman; Roel Vermeulen; Hans Kromhout
Journal:  Int Arch Occup Environ Health       Date:  2005-05-11       Impact factor: 3.015

4.  Occupational exposure to chemotherapy of pharmacy personnel at a single centre.

Authors:  Raveena Ramphal; Tejinder Bains; Geneviève Goulet; Régis Vaillancourt
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

5.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

6.  Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide.

Authors:  P J Sessink; E D Kroese; H J van Kranen; R P Bos
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

7.  Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products.

Authors:  Matthew D Zock; Scott Soefje; Keith Rickabaugh
Journal:  J Oncol Pharm Pract       Date:  2010-06-28       Impact factor: 1.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.